Decentralized study of COVID Vaccine Antibody Response (STOPCoV): Results of a participant satisfaction survey.

The Covid-19 pandemic required many clinical trials to adopt a decentralized framework to continue research activities during lock down restrictions. The STOPCoV study was designed to assess the safety and efficacy of Covid-19 vaccines in those aged 70 and above compared to those aged 30-50 years of...

Full description

Bibliographic Details
Main Authors: Rizani Ravindran, Leah Szadkowski, Leif Erik Lovblom, Rosemarie Clarke, Qian Wen Huang, Dorin Manase, Laura Parente, Sharon Walmsley, STOPCoV research team
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-05-01
Series:PLOS Digital Health
Online Access:https://doi.org/10.1371/journal.pdig.0000242